Interact to see
Advertisement
Advertisement
FTAHX vs RITGX
FTAHX vs RITGX Comparison
Open Charts FTAHX vs RITGX
American Funds American High-Inc 529-F-3
Price$9.69
Change-$0.01 (-0.10%)
VolumeN/A
Net Assets23.73B
American Funds American High-Inc R6
Price$9.69
Change-$0.01 (-0.10%)
VolumeN/A
Net Assets23.73B
FTAHX vs RITGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
FUNDAMENTALS
Fundamentals
FTAHX (23.7B) and RITGX (23.7B) have equal amount of cash in the bank . RITGX (6.79) and FTAHX (6.72) have matching dividends . FTAHX was incepted earlier than RITGX: FTAHX (5 years) vs RITGX (16 years). FTAHX (0.38) is less costly to investors than RITGX (0.32). FTAHX (39.00) and RITGX (39.00) have comparable annual turnover. FTAHX (250) and RITGX (250) have matching initial minimum investment requirements. RITGX (9.19) and FTAHX (9.11) have marching annual gain over last year.
| FTAHX | RITGX | FTAHX / RITGX | |
| Total Expense Ratio | 0.38 | 0.32 | 119% |
| Annual Report Gross Expense Ratio | 0.38 | 0.32 | 119% |
| Fund Existence | 5 years | 16 years | - |
| Gain YTD | 2.051 | 2.075 | 99% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 250 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 23.7B | 23.7B | 100% |
| Annual Yield % from dividends | 6.72 | 6.79 | 99% |
| Returns for 1 year | 9.11 | 9.19 | 99% |
| Returns for 3 years | 22.52 | 22.77 | 99% |
| Returns for 5 years | N/A | 43.66 | - |
| Returns for 10 years | N/A | 65.74 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LSSIX | 27.13 | 0.04 | +0.15% |
| Loomis Sayles Small Cap Growth Instl | |||
| NBSSX | 31.93 | N/A | N/A |
| Neuberger Berman Focus Investor | |||
| MLMSX | 21.71 | N/A | N/A |
| Morgan Stanley Instl Global Core R6 | |||
| IJMAX | 15.00 | -0.01 | -0.07% |
| VY® JPMorgan Mid Cap Value A | |||
| JDEAX | 42.82 | -0.04 | -0.09% |
| JPMorgan US Research Enhanced Equity A | |||